Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects

Phase 1CompletedNCT00494962

Wyeth is now a wholly owned subsidiary of Pfizer40 enrolled

Overview

To determine the bioequivalence between two 5-mg tablets of lecozotan and the new 10-mg tablet of lecozotan.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Alzheimer Disease

Interventions

lecozotan SRDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion criteria: * Generally healthy, man and women, aged 18 to 50 years. Exclusion criteria: * History or active presence of clinically important medical disease.

Locations (1)

Unnamed facility

Neuss, Germany

Outcomes

Primary Outcomes

Pharmacokinetic (PK) analyses

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.